USANA Health Sciences, Inc.
NYSE:USNAPackaged Foods
+$0.71 today
- Market cap
- $244.42M
- Beta
- 0.77
- P/E (TTM)
- 39.6
- EPS (TTM)
- $0.48
Volume 0.15M
Average 0.12M
USNA Free Cash Flow
Operating cash flow minus capital expenditures: cash available for debt repayment, dividends, and buybacks.
USANA Health Sciences, Inc.NYSE: USNA
Free Cash Flow · Q1 FY2026 · quarter ended Apr 2026
Free cash flow declines year over year
Q1 FY2026 free cash flow of $7.11M fell 43.9% year over year, ahead of the -94.0% change in trailing-twelve-month free cash flow. Over 3 fiscal years it compounded at -55.0% a year.
Context
- Free cash flow amounted to 0.9% of revenue in FY2025, down 5.0 pp from a year earlier.
- Free cash flow increased in 0 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of -43.9% holds above the trailing-twelve-month pace of -94.0%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Free Cash Flow history
USD · from the cash flow
- Latest · FY2025
- 8.53M USD
- Year-over-year change
- -83.3%
- 4-year CAGR
- -47.1%
| Period | Period end | Free Cash Flow | YoY change |
|---|---|---|---|
| FY2025 | 2026-01-03 | 8.53M | -83.3% |
| FY2024 | 2024-12-28 | 50.92M | -9.3% |
| FY2023 | 2023-12-31 | 56.15M | -40.0% |
| FY2022 | 2022-12-31 | 93.5M | -13.8% |
| FY2021 | 2021-12-31 | 108.46M | — |
Free Cash Flow vs competitors
How USNA compares with its peers on the latest reported figures
- Peers report in different currencies, so free cash flow is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of -94.0% is the 7th highest of 8, against a peer median of -58.5%.
- Free cash flow amounts to 0.3% of revenue for USNA, versus a peer median of 4.8%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2025 | CN¥676.97M CNY | +33.5% | — | 2.8% | |
WESTWestrock Coffee Company, LLC | LTM Mar 2026 | $63.37M USD | -63.9% | -3.5% | 4.9% |
| LTM Apr 2026 | $47.11M USD | -60.3% | — | 2.6% | |
| LTM Mar 2026 | R$46.82M BRL | +256.1% | -27.3% | 8.6% | |
| LTM Mar 2026 | $20.73M USD | -530.1% | — | 9.0% | |
| LTM Apr 2026 | $9.13M USD | +199.4% | +25.7% | 4.8% | |
| LTM Apr 2026 | $2.96M USD | -94.0% | -55.0% | 0.3% | |
| LTM Mar 2026 | $2.02M USD | -58.5% | -54.9% | 0.5% | |
| Peer median (excluding USNA) | — | -58.5% | -15.4% | 4.8% | |
Competitors are the stored peer set for USNA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Jan 2026 |
|---|---|---|---|---|---|
| Net Income | 116.51M | 69.35M | 63.79M | 42.06M | 10.76M |
| Depreciation & Amortization | 22.19M | 21.41M | 20.4M | 22.23M | 32.56M |
| Deferred Income Tax | (2.97M) | (7.18M) | (2.75M) | (6.74M) | (7.13M) |
| Stock-Based Compensation | 14.3M | 13.49M | 14.6M | 14.56M | 13.83M |
| Change in Working Capital | (28.86M) | 771K | (28M) | (13M) | (43.08M) |
| Accounts Receivables | 0 | 0 | 0 | 0 | 0 |
| Inventory | (10.5M) | 15.8M | 2.35M | (2.12M) | (34.69M) |
| Accounts Payables | (4.57M) | (2.66M) | (428K) | (1.27M) | 5.2M |
| Other Working Capital | (13.79M) | (12.37M) | (29.92M) | (9.62M) | (13.6M) |
| Other Non-Cash Items | 61K | 6.07M | 2.61M | 1.89M | 15.41M |
| Operating Cash Flow | 121.23M | 103.9M | 70.64M | 60.99M | 22.35M |
| Capital Expenditures | (12.76M) | (10.4M) | (14.49M) | (10.07M) | (13.82M) |
| Acquisitions (Net) | (1.94M) | (6.53M) | 0 | (203.34M) | 0 |
| Purchases of Investments | (1.56M) | 0 | (1.27M) | (870K) | 0 |
| Sales of Investments | 1.94M | 4.56M | 3.78M | 1.13M | 0 |
| Other Investing Activities | 131K | 7K | 15K | 64K | 3.7M |
| Investing Cash Flow | (14.19M) | (12.37M) | (11.98M) | (213.09M) | (10.13M) |
| Debt Repayment | 0 | 0 | 792K | 22.22M | (9M) |
| Common Stock Issued | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased | (177.84M) | (25.38M) | (11.6M) | (9.44M) | (27.51M) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (3.58M) | (4.71M) | (3.43M) | (3.22M) | (4.1M) |
| Financing Cash Flow | (181.41M) | (30.09M) | (14.24M) | 9.55M | (40.6M) |
| Effect of Forex Changes | 2.09M | (13.78M) | (2.5M) | (6.19M) | 5.11M |
| Net Change in Cash | (72.28M) | 47.67M | 41.93M | (148.74M) | (23.27M) |
| Free Cash Flow | 108.46M | 93.5M | 56.15M | 50.92M | 8.53M |
USANA Health Sciences, Inc.
NYSE:USNA
Intrinsic Alpha fair value
Locked
Current Price
$13.22
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.